N-acyl amino acid derivatives for treating skin conditions such as cellulite
The invention relates to small molecules having biological and therapeutic activity. Particularly, the invention relates to small molecules having lipolytic and anti-adipogenic activity. Two examples of such molecules are 4-methyl-2-(octanoylamino) pentanoic acid and N-isopentyloctanamide. The invention further relates to methods of preventing or treating skin conditions such as cellulite using small molecules having lipolytic and anti-adipogenic activity.
1. A method of stimulating lipolysis in one or more adipocytes of a mammal, said method comprising administering to the skin tissue of said mammal a composition comprising a pharmaceutically acceptable carrier and a pharmaceutically effective amount of a compound, or salt thereof, wherein the compound is:
2. The method of claim 1 , wherein said composition further comprises carnitine, resveratrol, isoproterenol, aminophylline, theophylline, or caffeine.
3. The method of claim 1 , wherein said composition is administered to skin tissue superficial to the subcutaneous layer.
4. The method of claim 1 , wherein said composition is directly injected into the subcutaneous layer of the skin tissue.
5. A method of stimulating lipolysis in one or more adipocytes of a mammal, said method comprising administering to the skin tissue of said mammal a composition comprising a pharmaceutically acceptable carrier and a pharmaceutically effective amount of a compound or pharmaceutically acceptable salts thereof, wherein the compound is of the formula:
R 1 —CO—NH—R 2 ; wherein
R 1 is a saturated or unsaturated aliphatic chain of 5 to 9 carbon atoms,
R 2 is an alkyl of 5 to 9 carbon atoms, and wherein the R 1 —C(O) portion of the formula is a fatty acyl group.
6. The method of claim 5 , wherein the fatty acyl group is an octanoyl group.
7. The method of claim , wherein the fatty acyl group is saturated.
8. The method of claim 5 , wherein said composition is in the form of an aerosol, emulsion, liquid, lotion, cream, paste, ointment, powder, or foam.
9. The method of claim 5 , wherein said composition further comprises carnitine, resveratrol, isoproterenol, aminophylline, theophylline, or caffeine.
10. The method of claim 5 , wherein said composition is administered to skin tissue superficial to the subcutaneous layer or directly injected into the subcutaneous layer.
11. A method of reducing adipogenesis in subcutaneous tissue of a mammal, said method comprising administering to the skin tissue of said mammal a composition comprising a pharmaceutically acceptable carrier and a pharmaceutically effective amount of a compound, or salt thereof, wherein the compound is:
12. The method of claim 11 , wherein said composition further comprises carnitine, resveratrol, isoproterenol, aminophylline, theophylline, or caffeine.
13. The method of claim 11 , wherein said composition is administered to skin tissue superficial to the subcutaneous layer.
14. The method of claim 11 , wherein said composition is directly injected into the subcutaneous layer of the skin tissue.
15. A method of reducing adipogenesis in subcutaneous tissue of a mammal, said method comprising administering to the skin tissue of said mammal a composition comprising a pharmaceutically acceptable carrier and a pharmaceutically effective amount of a compound or pharmaceutically acceptable salts thereof, wherein the compound is of the formula:
R 1 —CO—NH—R 2 ; wherein
R 1 is a saturated or unsaturated aliphatic chain of 5 to 9 carbon atoms,
R 2 is an alkyl of 5 to 9 carbon atoms, and wherein the R 1 —C(O) portion of the formula is a fatty acyl group.
16. The method of claim 15 , wherein the fatty acyl group is an octanoyl group.
17. The method of claim 15 , wherein the fatty acyl group is saturated.
18. The method of claim 15 , wherein said composition is in the form of an aerosol, emulsion, liquid, lotion, cream, paste, ointment, powder, or foam.
19. The method of claim 15 , wherein said composition further comprises carnitine, resveratrol, isoproterenol, aminophylline, theophylline, or caffeine.
20. The method of claim 15 , wherein said composition is administered to skin tissue superficial to the subcutaneous layer or directly injected into the subcutaneous layer.